ZONTAL offers the leading data platform for the life science industry. We make digital transformation a reality as we deliver game changing solutions to some of the most complex enterprises. We reduce IT overhead, enable AI/ML applications, optimize time-to-market, and increase compliance. ZONTAL has offices in the US, Europe and Asia. Together with our integration and service partners, ZONTAL supports our customers globally, in any country and any time-zone.
Integrations
Installations
Worldwide Offices
Files analyzed monthly
Data-centric workflows and full lab automation enable efficient digital management, improve research outcomes, reduce IT footprint, and lower operational costs.
Intelligent ingests facilitate efficient data management for all data formats and fully integrate scientific and non-scientific data through semantic technologies.
Attain truly findable, accessible, interoperable, and reusable (FAIR) data to eliminate the need for repeated experiments and establish a foundation for machine learning and AI.
Generate submission documentation automatically for faster time-to-market and always maintain highest integrity throughout the product lifecycle.
Successful data management creates new insights from reusing data enriched with context, process, and product information.
Quickly connect to all data sources and consumers across the entire enterprise for unambiguous communication and rapid integration.
With 6+ years of consultancy experience in the pharmaceutical industry, ZONTAL has the knowledge and understanding to effectively address the unique challenges and needs of life sciences organizations.
Our digital hub solution is the first regulatory compliant out-of-the-box solution in the industry, ensuring that all of your information is accessible, reusable, and fully compliant.
Our products are designed with scalability and intuitive design in mind, enabling quick and broad adoption within large companies. This leads to reduced IT overhead and optimized time-to-market.
Our integrations create intelligent information for data-driven decision making, allowing our customers to gain full access to the hidden value in their previously disjoint data.
Across 20 years of consultancy in the pharmaceutical industry, Wolfgang Colsman experienced that the lack of integration between data systems is one of the biggest challenges to life sciences organizations in their digital transformation. Wolfgang founded ZONTAL in 2016 to solve pharmaceutical data challenges worldwide. Together with leading pharma companies, Wolfgang created ZONTAL’s Life Science Data Platform – a digital lab solution that empowers global enterprises to integrate, enrich, preserve, and reuse their data across the business value chain. Further, Wolfgang inspired ZONTAL’s focus on scalability and intuitive design, enabling quick and broad adoption within large companies worldwide.
Bill Russo is the Vice President of Sales at ZONTAL. Over the past 20 years, Bill has worked with customers to understand the value of Enterprise Data Management, ELNs, LIMS, and Registration Systems across the discovery to manufacturing continuum. Bill uses his 7 years of experience as a bench scientist to ensure that every deployed solution provides tangible benefits to the end-user community while keeping the corporate goals in focus.
Prof. Dennis Della Corte leads the Life Science Analytics team as Chief Science Officer of ZONTAL and is the acting director of the Consortium of Molecular Design at Brigham Young University. His work is focussed on building the laboratory of the future, through better datasets, algorithms, training strategies. Formerly, he worked at Bayer AG as Global IT Project manager and obtained a PhD in Computational Biophysics at FZ Jülich in collaboration with Stanford University. He also holds Master's Degrees in Biomedical Engineering and Medical Physics.
Sample content
Sample content
Sample content
In a new paper, researchers at IBM Research recently presented a
Molecular docking is a critical task in drug design, as it
RFDiffusion is a new method for protein design that leverages the power
Molecular docking tools are commonly used in drug discovery to computationally
In the past two months, DALL·E 2 has taken over the internet. From
